CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 119 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,572,622 | +305.8% | 52,879 | +145.9% | 0.00% | – |
| Q2 2023 | $387,574 | +17.1% | 21,508 | +4.4% | 0.00% | – |
| Q1 2023 | $330,932 | -12.2% | 20,606 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $377,090 | -6.8% | 20,606 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $404,702 | +9.4% | 20,606 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $370,000 | -3.6% | 19,860 | +13.5% | 0.00% | 0.0% |
| Q1 2022 | $384,000 | -12.1% | 17,504 | +13.9% | 0.00% | 0.0% |
| Q4 2021 | $437,000 | +47.1% | 15,372 | +8.9% | 0.00% | 0.0% |
| Q3 2021 | $297,000 | +11.7% | 14,112 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $266,000 | +31.0% | 14,112 | +6.4% | 0.00% | – |
| Q1 2021 | $203,000 | +14.7% | 13,260 | +6.0% | 0.00% | – |
| Q4 2020 | $177,000 | – | 12,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 1,862,286 | $27,376,000 | 8.48% |
| Vivo Capital, LLC | 3,320,801 | $48,816,000 | 4.42% |
| Burrage Capital Management LLC | 282,272 | $4,022,000 | 3.96% |
| Opaleye Management Inc. | 368,750 | $5,421,000 | 1.44% |
| Perceptive Advisors | 2,587,953 | $38,042,000 | 0.99% |
| RA Capital Management | 1,961,209 | $28,830,000 | 0.91% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,073,000 | 0.62% |
| EcoR1 Capital, LLC | 350,000 | $5,145,000 | 0.54% |
| Orbimed Advisors | 2,039,282 | $29,977,000 | 0.50% |
| Eventide Asset Management | 947,000 | $13,921,000 | 0.45% |